Preview

Neurology, Neuropsychiatry, Psychosomatics

Advanced search

THERAPY FOR EPILEPSY IN MIDDLE-AGED AND ELDERLY PATIENTS

https://doi.org/10.14412/2074-2711-2009-25

Full Text:

Abstract

Moscow State Medical University of Dentistry The authors consider the specific features of epilepsy in middle-aged and elderly patients: a preponderance of focal symptomatic and cryptogenic epilepsies, a frequent combination with concomitant mental and somatic diseases, and a relative efficacy of small-dose antiepileptic drugs (AED). Choice of therapy is noted to depend on the form of epilepsy/type of seizures, comorbidity and used medicines. A major focus is on the use of basic AEDs R carbamazepine and valproates. Data on the promise for using depakine chronosphere in middle-aged and elderly
patients are given.

References

1. <div><p>Hauser W.A., Annegers J.F., Kurland L.T. Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935-1984. Epilepsia 1993;34:453-68.</p><p>Власов П.Н. Клиническая фармакология лекарственных средств, применяемых при судорожном синдроме. В кн: Клиническая фармакология. Национальное руководство.</p><p>Национальный проект «Здоровье». М.: Геотар-Медиа, 2008;882.</p><p>Власов П.Н. Алгоритмы диагностики и терапии эпилепсии у взрослых в поликлинических условиях. Фарматека 2006;7:96-104.</p><p>Зенков Л.Р. Как улучшить лечение эпилепсии в России. РМЖ 2003;1:8.</p><p>Карлов В.А. Стратегия и тактика терапии эпилепсии сегодня. Невропатол и психиатр 2004;8:28-34.</p><p>Мухин К.Ю., Петрухин А.С. Эпилептические синдромы. Диагностика и стандарты терапии (справочное руководство). М., 2005;143 с.</p><p>Dulac O. and Alvarez J.-Claude.</p><p>Bioequivalence of a new sustained-release formulation of sodium valproate, valproate modified-release granules, compared with existing sustained-release formulations after once- , or twice-daily administration. Pharmacotherapy 2005;25(1):35-42. 8.</p><p>The epilepsies: the diagnosis and management of the epilepsies in adults and children in primary and secondary care. Clinical guideline 20.</p><p>NICE. London, 2004;73 p.</p><p>Glauser T. , Ben-Menachem E., Bourgeois B. et al. ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia 2006;47:1094-120.</p><p>Karceski S., Morrell M., Carpenter D. Treatment of epilepsy in adults: expert opinion. Epilepsy&amp;Behavior 2005;1-64.</p><p>Sillanpaa M. Carbamazepine. The treatment of epilepsy. Second edition. 2004. Shorvon S., Perucca E., Fish D. et al. Blackwell science 345-57.</p><p>Власов П.Н. Дифференциальная диагностика основных пароксизмальных состояний в практике невролога и терапевта. Фарматека 2008;5:91-4.</p></div><br />


For citation:


Vlasov P.N., Andreeva O.V., Vlasov P.N., Andreyeva O.V. THERAPY FOR EPILEPSY IN MIDDLE-AGED AND ELDERLY PATIENTS. Neurology, Neuropsychiatry, Psychosomatics. 2009;1(1):54-58. (In Russ.) https://doi.org/10.14412/2074-2711-2009-25

Views: 320


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2074-2711 (Print)
ISSN 2310-1342 (Online)